share_log

歌禮製藥-B：二零二四年股東週年大會通知

ASCLETIS-B: Notice of 2024 Annual General Meeting

Hong Kong Stock Exchange ·  Apr 26 16:53
Summary by Futu AI
歌禮製藥-B（Ascletis Pharma Inc.）將於2024年5月23日在中國浙江省杭州市召開股東週年大會，討論包括審核2013年度財務報表、董事會報告及核數師報告在內的多項議程。會議將重選顧炯先生和華林女士為獨立非執行董事，並授權董事會釐定董事酬金。此外，會議將續聘畢馬威會計師事務所為核數師並授權董事會釐定其酬金。大會還將考慮通過授權董事在特定期間內配發、發行及處理股份的普通決議案，包括購回股份的權力。股份過戶登記將於2024年5月20日至23日暫停辦理，以釐定有權出席大會並投票的股東身份。
歌禮製藥-B（Ascletis Pharma Inc.）將於2024年5月23日在中國浙江省杭州市召開股東週年大會，討論包括審核2013年度財務報表、董事會報告及核數師報告在內的多項議程。會議將重選顧炯先生和華林女士為獨立非執行董事，並授權董事會釐定董事酬金。此外，會議將續聘畢馬威會計師事務所為核數師並授權董事會釐定其酬金。大會還將考慮通過授權董事在特定期間內配發、發行及處理股份的普通決議案，包括購回股份的權力。股份過戶登記將於2024年5月20日至23日暫停辦理，以釐定有權出席大會並投票的股東身份。
Ascletis Pharma Inc. (Ascletis Pharma Inc.) will hold its Annual General Meeting on 23 May 2024 in Hangzhou, Zhejiang, China, to discuss a number of agendas including the audit of the 2013 financial statements, the Board of Directors reports and the auditor's report. THE MEETING WILL RE-ELECT MR. GU JIONG AND MS. HUA LIN AS INDEPENDENT NON-EXECUTIVE DIRECTORS AND AUTHORIZE THE BOARD TO DETERMINE THE DIRECTORS' REMUNERATION. In addition, the meeting will renew the appointment of Pimawy Accounting Firm as auditor and authorize the Board of Directors to determine its remuneration. THE GENERAL MEETING WILL ALSO CONSIDER THE ADOPTION OF ORDINARY RESOLUTIONS TO DISTRIBUTE, ISSUE AND PROCESS SHARES WITHIN A SPECIFIED PERIOD OF TIME, INCLUDING THE POWER TO REPURCHASE SHARES. The registration of shares will be suspended from 20 to 23 May 2024 to determine the identity of shareholders entitled to attend and vote at the general meeting.
Ascletis Pharma Inc. (Ascletis Pharma Inc.) will hold its Annual General Meeting on 23 May 2024 in Hangzhou, Zhejiang, China, to discuss a number of agendas including the audit of the 2013 financial statements, the Board of Directors reports and the auditor's report. THE MEETING WILL RE-ELECT MR. GU JIONG AND MS. HUA LIN AS INDEPENDENT NON-EXECUTIVE DIRECTORS AND AUTHORIZE THE BOARD TO DETERMINE THE DIRECTORS' REMUNERATION. In addition, the meeting will renew the appointment of Pimawy Accounting Firm as auditor and authorize the Board of Directors to determine its remuneration. THE GENERAL MEETING WILL ALSO CONSIDER THE ADOPTION OF ORDINARY RESOLUTIONS TO DISTRIBUTE, ISSUE AND PROCESS SHARES WITHIN A SPECIFIED PERIOD OF TIME, INCLUDING THE POWER TO REPURCHASE SHARES. The registration of shares will be suspended from 20 to 23 May 2024 to determine the identity of shareholders entitled to attend and vote at the general meeting.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.